News & Media
March 27, 2023
Andelyn Biosciences Announce New Chief Commercial Officer
(COLUMBUS, Ohio) – Andelyn Biosciences announces the appointment of Matt Niloff as Chief Commercial Officer (CCO). Niloff will lead the...
March 8, 2023
Inspiring the Next Generation of Women in Life Sciences
In honor of International Women's Day, EPM brings you an exclusive roundup of inspiring commentary from over 25 empowering women in the STEM and life sciences industries. These women share their personal experiences of working in these fields, the challenges they face, and their tips for encouraging young women who are wishing to pursue a career in STEM.
March 1, 2023
Andelyn Biosciences Board of Directors Announce New CEO
(COLUMBUS, Ohio) – Andelyn Biosciences Chief Operations Officer Wade Macedone has been promoted to CEO of the gene and cell...
February 18, 2023
Suspension Cell Culture in Cell and Gene Therapy
The Growing Demand for Suspension Cell Culture Platforms The biopharmaceutical sector is growing and demand for viral vectors as tools...
February 18, 2023
Genetic Engineering
Delivering Genetic Editing Therapies to Market In the past 10 years, our understanding of molecular biology and genetic engineering has...
February 1, 2023
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...
November 28, 2022
Trends in AAV development and manufacturing for gene therapies
Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...
July 11, 2022
Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture
John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.
February 28, 2022
Andelyn Biosciences Observes Rare Disease Day
Observed every year on the last day in February, Rare Disease Day works to raise awareness for rare diseases and...
February 14, 2022
Reliability and the Future of Cell & Gene Therapies
Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.